Norges Bank’s Kite Pharma, Inc. KITE Stock Holding History

Norges Bank’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-320,779	Closed	-$57.7M	–	2167
2017 Q3	$57.7M	Hold	320,779	–	–	0.02%	693
2017 Q2	$33.3M	Sell	320,779 -44,966	-12%	-$3.67M	0.01%	1034
2017 Q1	$28.7M	Sell	365,745 -10,000	-3%	-$618K	0.01%	1127
2016 Q4	$16.8M	Hold	375,745	–	–	0.01%	1433
2016 Q3	$20M	Buy	375,745 +52,380	+16%	+$2.92M	0.01%	1245
2016 Q2	$16.2M	Buy	323,365 +21,196	+7%	+$1.04M	0.01%	1334
2016 Q1	$13.9M	Sell	302,169 -20,777	-6%	-$1.01M	0.01%	1390
2015 Q4	$19.9M	Buy	322,946 +54,800	+20%	+$3.86M	0.01%	1162
2015 Q3	$14.9M	Buy	+268,146	New	+$16.9M	0.01%	1309

Norges Bank's KITE Position: Q4 2017 in Review

Norges Bank sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 320,779 shares — an estimated $57.7M sold.

Norges Bank first reported a position in KITE in Q3 2015 and held it in 9 quarters. The position peaked at $57.7M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

Norges Bank reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
Norges Bank sold 320,779 Kite Pharma, Inc. shares in Q4 2017, an estimated $57.7M.
Norges Bank first reported a position in Kite Pharma, Inc. in Q3 2015 and held it in 9 quarters.
Norges Bank's Kite Pharma, Inc. position peaked at $57.7M in Q3 2017.
0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Norges Bank's 13F filing for Q4 2017, filed 9 Feb 2018.